Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Breast Neoplasms × Blood Specimen Collection × Clear all

Phase

Phase NA 37 Phase EARLY_PHASE1 5 Phase 2 4 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myeloid, Accelerated Phase 2 Blast Crisis 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Graft vs Host Disease 1 Gastrointestinal Stromal Tumors 1 Breast Neoplasms 1

Interventions

Trastuzumab 53 Paclitaxel 50 Cyclophosphamide 35 pembrolizumab 30 Fulvestrant 27 Capecitabine 26 Carboplatin 23 Docetaxel 20 Letrozole 18 Doxorubicin 16 durvalumab 14 palbociclib 13 abemaciclib 13 eribulin 11 Vinorelbine 11 Filgrastim 11 Albumin-Bound Paclitaxel 11 Lapatinib 10 Gemcitabine 10 Bevacizumab 10 ribociclib 9 pertuzumab 9 Taxes 9 trastuzumab deruxtecan 8 olaparib 8 neratinib 8 fludarabine 8 Peripheral Blood Stem Cell Transplantation 8 Everolimus 8 130-nm albumin-bound paclitaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04454528 2026-03-10

BreastVAX

Abramson Cancer Center at Penn Medicine

Phase 1/2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡